carbidopa-levodopa 25-100 mg

DRUG2 trials

Sponsors

Snyder, Robert W., M.D., Ph.D., P.C.

Conditions

Age-related Macular DegenerationMacula; DegenerationRetina

Phase 2

A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration

WithdrawnNCT02873351

Snyder, Robert W., M.D., Ph.D., P.C.Age-related Macular Degeneration

Start: 2019-09-30End: 2020-12-31Updated: 2019-04-05

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

CompletedNCT03197493

Snyder, Robert W., M.D., Ph.D., P.C.Macula; Degeneration, Retina

Start: 2017-08-01End: 2020-07-09Updated: 2025-09-12